For: | Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: A meta-analysis. World J Gastroenterol 2014; 20(29): 10174-10182 [PMID: 25110446 DOI: 10.3748/wjg.v20.i29.10174] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i29/10174.htm |
Number | Citing Articles |
1 |
Wei-Ju Huang, Yung-Ming Jeng, Hong-Shiee Lai, Fang-Yu Bonnie Sheu, Po-Lin Lai, Ray-Hwang Yuan. Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma. Langenbeck's Archives of Surgery 2015; 400(6): 725 doi: 10.1007/s00423-015-1329-4
|
2 |
Cody R. Criss, Mina S. Makary. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors. Biology 2023; 12(7): 999 doi: 10.3390/biology12070999
|
3 |
Yih-Jyh Lin, Chia-Ni Lin, Tannaz Sedghi, Sylvia H. Hsu, Cary P. Gross, Jung-Der Wang, Shi-Yi Wang, Nader Hanna. Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan. PLOS ONE 2020; 15(10): e0240542 doi: 10.1371/journal.pone.0240542
|
4 |
Qingsong Deng, Minglian He, Chunchuan Fu, Kai Feng, Kuansheng Ma, Leida Zhang. Radiofrequency ablation in the treatment of hepatocellular carcinoma. International Journal of Hyperthermia 2022; 39(1): 1052 doi: 10.1080/02656736.2022.2059581
|
5 |
Garrett Richard Roll, John Paul Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 1541 doi: 10.1016/B978-0-323-40232-3.00132-1
|
6 |
Biao Yang, Rui-yu Zan, Shi-yu Wang, Xiang-lian Li, Mao-ling Wei, Wen-hao Guo, Xin You, Jing Li, Zheng-yin Liao. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials. World Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0516-7
|
7 |
Jun Xie, Chunyao Zheng, Jinliang Xie, Fangfei Wang, Dingwei Liu, Rong Zeng, Chensong Yu, Sihai Chen. No significant relationship exists between tumor size and prognosis in distant metastatic hepatocellular carcinoma: a propensity score matching analysis based on SEER database. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02355-1
|
8 |
Nir Rozenblum, Evelyne Zeira, Viviana Scaiewicz, Baruch Bulvik, Svetlana Gourevitch, Hagit Yotvat, Eithan Galun, S. Nahum Goldberg. Oncogenesis: An “Off-Target” Effect of Radiofrequency Ablation. Radiology 2015; 276(2): 426 doi: 10.1148/radiol.2015141695
|
9 |
Olivier Sutter, Amina Fihri, Rafik Ourabia-Belkacem, Nicolas Sellier, Abou Diallo, Olivier Seror. Real-Time 3D Virtual Target Fluoroscopic Display for Challenging Hepatocellular Carcinoma Ablations Using Cone Beam CT. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533033818789634
|
10 |
Robert J. Wong, Aijaz Ahmed, Robert G. Gish. Elevated Alpha-Fetoprotein. Clinics in Liver Disease 2015; 19(2): 309 doi: 10.1016/j.cld.2015.01.005
|
11 |
Zhimei Huang, Yangkui Gu, Shaoyong Wu, Chunxiao Lai, Xiuchen Wang, Jinhua Huang. Computed tomography-guided radiofrequency ablation of the retained iodized oil after simultaneous combination with transarterial embolization in small recurrent or residual hepatocellular carcinoma. Journal of Interventional Medicine 2020; 3(1): 49 doi: 10.1016/j.jimed.2020.01.008
|
12 |
Qiao Zhang, Feng Xia, Hengyi Gao, Zhenheng Wu, Wenjing Cao, Qingfeng Xiang, Zhifeng Guan, Yang Su, Weiqiao Zhang, Weiqiang Chen, Ali Mo, Shuqun Li. Circulating Tumor Cells as an Indicator of Treatment Options for Hepatocellular Carcinoma Less Than or Equal to 3 cm in Size: A Multi-Center, Retrospective Study. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.895426
|
13 |
Toshiro Masuda, Toru Beppu, Hirohisa Okabe, Hidetoshi Nitta, Katsunori Imai, Hiromitsu Hayashi, Akira Chikamoto, Kenichiro Yamamoto, Satoshi Ikeshima, Masafumi Kuramoto, Shinya Shimada, Hideo Baba. Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasion. Hepatology Research 2016; 46(10): 985 doi: 10.1111/hepr.12637
|
14 |
Philippe Rochigneux, Jean-Charles Nault, Françoise Mallet, Anne-Sophie Chretien, Nathalie Barget, Alejandro J. Garcia, Lucie Del Pozo, Valérie Bourcier, Lorraine Blaise, Véronique Grando-Lemaire, Gisèle N’Kontchou, Pierre Nahon, Olivier Seror, Marianne Ziol, Nathalie Ganne-Carrié, Daniel Olive. Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma. OncoImmunology 2019; 8(8) doi: 10.1080/2162402X.2019.1615818
|
15 |
Zhaonan Li, Dechao Jiao, Xinwei Han, Guangyan Si, Yahua Li, Juanfang Liu, Yanneng Xu, Bo Zheng, Xun Zhang. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma. Cancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-0294-5
|
16 |
Youqing Wang, Luyao Zhang, Fang Han, Runhua Li, Yongran Cheng, Xiyi Jiang, Liangyou Wang, Jinfei Chen, Jianguang Ji, Yuhua Zhang, Tianhui Chen. Using Period Analysis to Timely Assess and Predict 5-Year Relative Survival for Liver Cancer Patients From Taizhou, Eastern China. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.920094
|
17 |
Nir Rozenblum, Evelyne Zeira, Viviana Scaiewicz, Baruch Bulvik, Svetlana Gourevitch, Hagit Yotvat, Eithan Galun, S. Nahum Goldberg. Oncogenesis: An “Off-Target” Effect of Radiofrequency Ablation. Radiology 2015; 276(2): 426 doi: 10.1148/radiol.2015141695
|
18 |
Masato Higurashi, Tsuyoshi Maruyama, Yusuke Nogami, Fumihiro Ishikawa, Yukiko Yoshida, Kazunori Mori, Ken-ichi Fujita, Motoko Shibanuma. High expression of FOXM1 critical for sustaining cell proliferation in mitochondrial DNA-less liver cancer cells. Experimental Cell Research 2020; 389(1): 111889 doi: 10.1016/j.yexcr.2020.111889
|
19 |
Stacy K. Y. Fan, Brian Li, Qingyang Chen, Mehran Midia. Impact of Interventional Oncology Therapies on Tumor Microenvironment and Strategies to Enhance Their Efficacy. American Journal of Roentgenology 2018; 210(3): 648 doi: 10.2214/AJR.16.17677
|
20 |
Nicolò Gennaro, Simone Schiaffino, Giovanni Mauri, Lorenzo Monfardini. The What, the Why, and the How of Liver Ablations: A Practical Guide for the Medical Oncologist. Oncology 2021; 99(11): 722 doi: 10.1159/000518358
|
21 |
Pankaj Gupta, Naveen Kalra, Sreedhara B. Chaluvashetty, Shivanand Gamangatti, Amar Mukund, Razik Abdul, VS Shyam, Sanjay Saran Baijal, Chander Mohan. Indian College of Radiology and Imaging Guidelines on Interventions in Hepatocellular Carcinoma. Indian Journal of Radiology and Imaging 2022; 32(04): 540 doi: 10.1055/s-0042-1754361
|
22 |
Xingshun Qi, Yan Zhao, Hongyu Li, Xiaozhong Guo, Guohong Han. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses. Oncotarget 2016; 7(23): 34703 doi: 10.18632/oncotarget.9157
|
23 |
Di Zhou, Gang-Feng Hu, Wei-Chen Gao, Xiao-Yu Zhang, Wen-Bin Guan, Jian-Dong Wang, Fei Ma. Hepatocellular carcinoma with tumor thrombus in bile duct: A proposal of new classification according to resectability of primary lesion. World Journal of Gastroenterology 2020; 26(44): 7005-7021 doi: 10.3748/wjg.v26.i44.7005
|
24 |
Dan Cui, Hongye Wang, Zhi Wang, Zhaorong Wu, Min Ding, Linke Bian, Jiachang Chi, Bo Zhai. Upregulation of EFCAB7 after radiofrequency ablation promoting hepatocellular carcinoma metastasis and survival by regulating PARK7. Aging 2024; 16(17): 12252 doi: 10.18632/aging.206073
|
25 |
Lumin Chen, Jihong Sun, Xiaoming Yang. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status. Cancer Letters 2016; 370(1): 78 doi: 10.1016/j.canlet.2015.09.020
|
26 |
Thuong G. Van Ha. Difficult Decisions in Hepatobiliary and Pancreatic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach 2016; : 139 doi: 10.1007/978-3-319-27365-5_12
|
27 |
Daniel Putzer, Peter Schullian, Gernot Eberle, Reto Josef Bale. Thermal ablation—an option in curative treatment of HCC. memo - Magazine of European Medical Oncology 2020; 13(2): 207 doi: 10.1007/s12254-020-00600-5
|
28 |
|
29 |
Shi-Lu Chen, Shi-Xun Lu, Li-Li Liu, Chun-Hua Wang, Xia Yang, Zhi-yi Zhang, Hui-Zhong Zhang, Jing-ping Yun. eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma. Translational Oncology 2018; 11(1): 125 doi: 10.1016/j.tranon.2017.11.001
|
30 |
松 王. Study of Pleural Effusion after Radiofrequency Ablation for Primary Hepatocellular Carcinoma. World Journal of Cancer Research 2017; 7(01): 6 doi: 10.12677/WJCR.2017.71002
|
31 |
Avik Majumdar, Davide Roccarina, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Management of people with early- or very early-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD011650.pub2
|
32 |
Karin Nielsen, Hester J. Scheffer, M. Petrousjka van den Tol, Anders Nilsson. Irreversible Electroporation in Clinical Practice. 2018; : 139 doi: 10.1007/978-3-319-55113-5_10
|
33 |
Masaya Miyazaki, Toshihiro Iguchi, Haruyuki Takaki, Takashi Yamanaka, Yoshitaka Tamura, Hiroyuki Tokue, Yozo Sato, Osamu Ikeda, Tadashi Shimizu, Koichiro Yamakado. Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts. Japanese Journal of Radiology 2016; 34(9): 647 doi: 10.1007/s11604-016-0569-8
|
34 |
|
35 |
Yi-xin Hu, Cui-ju Yan, Miao Yun, Wei Zheng, Xue-bin Zou, Ya-fang Zhang, Ru-shuang Mao, Ling-ling Li, Jian-hua Zhou. Contrast-enhanced ultrasound liver imaging reporting and data system v2017: patient outcomes after treatment for early-stage hepatocellular carcinoma nodules with category 3-5 and category M. The British Journal of Radiology 2023; doi: 10.1259/bjr.20220492
|
36 |
Francesco Izzo, Vincenza Granata, Roberto Grassi, Roberta Fusco, Raffaele Palaia, Paolo Delrio, Gianpaolo Carrafiello, Daniel Azoulay, Antonella Petrillo, Steven A Curley. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. The Oncologist 2019; 24(10): e990 doi: 10.1634/theoncologist.2018-0337
|
37 |
Tian Lan, Lei Chang, Rahmathullah MN, Long Wu, Yu-Feng Yuan. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma. Medicine 2016; 95(15): e3185 doi: 10.1097/MD.0000000000003185
|
38 |
Allison N. Martin, Luke R. Wilkins, Deepanjana Das, Lily E. Johnston, Todd W. Bauer, Reid B. Adams, Victor M. Zaydfudim. Efficacy of Radiofrequency Ablation versus Transarterial Chemoembolization for Patients with Solitary Hepatocellular Carcinoma ≤3 cm. The American Surgeon™ 2019; 85(2): 150 doi: 10.1177/000313481908500220
|
39 |
Shibin Du, Jian-Zhi Yang, Jing Chen, Wei-gang Zhou, Yan-Yan Sun, Scott M. Langevin. Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching. PLOS ONE 2020; 15(1): e0227242 doi: 10.1371/journal.pone.0227242
|
40 |
Fuan Wang, Chuan Xu, Guiling Li, Penghua Lv, Jianping Gu. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma. Experimental Cell Research 2021; 409(2): 112910 doi: 10.1016/j.yexcr.2021.112910
|
41 |
Shiv Bahadur, Prashant Kumar. Deep Learning for Targeted Treatments. 2022; : 229 doi: 10.1002/9781119857983.ch8
|
42 |
Pankaj Gupta, Shyamkumar N. Keshava, Naveen Kalra, Sreedhara B. Chaluvashetty, Amar Mukund, Shuvro H. Roy-Choudhury, Sanjay Saran Baijal, Anubhav Khandelwal, Venkatesh Hosur Ananthashayana, Sathya Narayanan R., Suyash S. Kulkarni, Nitin Sudhakar Shetty, Arun Gupta, Sanjay Gupta. Indian Society of Vascular and Interventional Radiology Expert Consensus Statements for Ablation in Hepatocellular Carcinoma: Part II. Journal of Clinical Interventional Radiology ISVIR 2020; 4(03): 175 doi: 10.1055/s-0040-1715775
|
43 |
Bin Chai, Wei Wang, Fuquan Wang, Guofeng Zhou, Chuansheng Zheng. Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma. International Journal of Hyperthermia 2021; 38(1): 1685 doi: 10.1080/02656736.2021.1970825
|